Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D08EMG
|
|||
Former ID |
DNC012717
|
|||
Drug Name |
(S)APOMORPHINE
|
|||
Synonyms |
S-(+)-apomorphine; S-apomorphine; UNII-LH812IV7LI; LH812IV7LI; CHEMBL416288; 39478-62-1; (6aS)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol; 4H-Dibenzo(de,g)quinoline-10,11-diol, 5,6,6a,7-tetrahydro-6-methyl-, (S)-; S(+)-APOMORPHINE; (+)-10,11-Dihydroxyaporphine; Apomorphine, S-; AC1LEHBI; Lopac-A-4393; Oprea1_044402; SCHEMBL6922802; GTPL8285; CTK1C3986; cid_6852389; BDBM29643; DTXSID40192615; MolPort-002-507-063; (6as)-10,11-dihydroxyaporphine; ZINC155525; PDSP1_001504
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C17H17NO2
|
|||
Canonical SMILES |
CN1CCC2=C3C1CC4=C(C3=CC=C2)C(=C(C=C4)O)O
|
|||
InChI |
1S/C17H17NO2/c1-18-8-7-10-3-2-4-12-15(10)13(18)9-11-5-6-14(19)17(20)16(11)12/h2-6,13,19-20H,7-9H2,1H3/t13-/m0/s1
|
|||
InChIKey |
VMWNQDUVQKEIOC-ZDUSSCGKSA-N
|
|||
CAS Number |
CAS 39478-62-1
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
11110737, 24671926, 26088392, 26754246, 35412028, 47252419, 47550611, 47623931, 50322704, 57408699, 57736768, 90451435, 103236763, 103923437, 108667036, 109885511, 126651798, 129497606, 131289772, 134349922, 135266545, 135609359, 138621171, 162517257, 179235808, 225157380, 232597267, 252166497, 252614855
|
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8285). | |||
REF 2 | Synthesis and dopamine receptor affinities of enantiomers of 2-substituted apomorphines and their N-n-propyl analogues. J Med Chem. 1990 Jun;33(6):1800-5. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.